NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings
Werte in diesem Artikel
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
Ashley Mastronardi delivers the pre-market update on August 27th
- Equities are up this morning as investors wait for chip giant Nvidia's Q2 earnings report. The company is set to release the earnings after market close this afternoon.
- As the most heavily weighted company in the S&P 500 at more than 8%, Nvidia's results will likely be felt by investors throughout the rest of the week and provide insight into the level of demand for AI.
- The major averages are coming off a day of fractional gains with investors shaking off President Trump's move to fire Fed Governor Lisa Cook ahead of the Fed's next policy meeting in Mid-September.
Opening Bell
Abbott (NYSE: ABT) and the Big Ten Conference are teaming up to address the worst blood shortage in a generation
Closing Bell
Van Eck celebrates the 70th anniversary of Van Eck and its first ETF listing
Click here to download the NYSE TV App

Video - https://mma.prnewswire.com/media/2759225/NYSE_Market_Update_August_27.mp4
Logo - https://mma.prnewswire.com/media/2581322/5479702/New_York_Stock_Exchange_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update--wall-street-braces-for-nvidias-earnings-302539988.html
Übrigens: Abbott Laboratories und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Abbott Laboratories
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Abbott Laboratories
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Abbott Laboratories
Analysen zu Abbott Laboratories
Datum | Rating | Analyst | |
---|---|---|---|
27.08.2020 | Abbott Laboratories Sell | Goldman Sachs Group Inc. | |
16.10.2018 | Abbott Laboratories Overweight | Barclays Capital | |
25.01.2018 | Abbott Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
15.12.2017 | Abbott Laboratories Outperform | BMO Capital Markets | |
19.10.2017 | Abbott Laboratories Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
16.10.2018 | Abbott Laboratories Overweight | Barclays Capital | |
25.01.2018 | Abbott Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
15.12.2017 | Abbott Laboratories Outperform | BMO Capital Markets | |
19.10.2017 | Abbott Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
19.10.2017 | Abbott Laboratories Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
23.07.2015 | Abbott Laboratories Equal Weight | Barclays Capital | |
27.03.2015 | Abbott Laboratories Equal Weight | Barclays Capital | |
30.01.2015 | Abbott Laboratories Equal Weight | Barclays Capital | |
07.01.2013 | Abbott Laboratories halten | Deutsche Bank Securities | |
29.11.2012 | Abbott Laboratories neutral | Sarasin Research |
Datum | Rating | Analyst | |
---|---|---|---|
27.08.2020 | Abbott Laboratories Sell | Goldman Sachs Group Inc. | |
25.10.2011 | Abbott Laboratories sell | Citigroup Corp. | |
05.10.2011 | Abbott Laboratories sell | Citigroup Corp. | |
22.11.2006 | Advanced Medical Optics sell | Citigroup | |
11.09.2006 | Abbott Laboratories reduce | UBS |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Abbott Laboratories nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen